Literature DB >> 12240552

Re-irradiation of the human spinal cord.

Peter Sminia1, Foppe Oldenburger, Ben J Slotman, Christoph J Schneider, Maarten C C M Hulshof.   

Abstract

PURPOSE: Experimental animal data give evidence of long-term recovery of the spinal cord after irradiation. By extrapolation of these data, re-irradiation regimens were designed for eight patients who required palliative radiotherapy. As a consequence of re-irradiation, their spinal cords were exposed to cumulative doses exceeding the tolerance dose. Radiobiological and clinical data are presented. PATIENTS AND
METHOD: Eight patients were re-irradiated on the cervical (n = 1), thoracic (n = 5) and lumbar (n = 2) spinal cord. The time interval between the initial and re-treatment ranged from 4 months to 12.7 years (median: 2.5 years). (Re-)treatment schemes were designed and analyzed on basis of the biologically effective dose (BED) according to the linear-quadratic model. The repair capacity (alpha/beta ratio) for the cervico-thoracic and lumbar spinal cord was assumed to be 2 Gy and 4 Gy, with a BEDtolerance of 100 Gy and 84 Gy, respectively.
RESULTS: The cumulative irradiation dose applied to the spinal cord varied between 125 and 172% of the BEDtolerance. During follow-up, ranging from 33 days to > 4.5 years (median: 370 days) none of the patients developed neurological complications. Seven patients died from tumor progression, and one patient is still alive.
CONCLUSION: Long-term recovery of the spinal cord from radiation injury, which has been demonstrated in rodents and primates, may also occur in humans.

Entities:  

Mesh:

Year:  2002        PMID: 12240552     DOI: 10.1007/s00066-002-0948-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  6 in total

1.  Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.

Authors:  L Vormittag; C Lemaire; D Radonjic; G Kornek; E Selzer
Journal:  Strahlenther Onkol       Date:  2012-02-10       Impact factor: 3.621

2.  In regards to decision making for reirradiation of a recurrent intramedullary spinal cord metastasis.

Authors:  Charles E Rutter; James B Yu; David J Carlson; Zain A Husain; Sherry Zhao; James Picone; Ranjit S Bindra
Journal:  J Radiosurg SBRT       Date:  2014

3.  Aortic dose constraints when reirradiating thoracic tumors.

Authors:  Jaden D Evans; Daniel R Gomez; Arya Amini; Neal Rebueno; Pamela K Allen; Mary K Martel; Justin M Rineer; Kie Kian Ang; Sarah McAvoy; James D Cox; Ritsuko Komaki; James W Welsh
Journal:  Radiother Oncol       Date:  2013-02-28       Impact factor: 6.280

4.  Stereotactic body radiotherapy for lesions of the spine and paraspinal regions.

Authors:  John W Nelson; David S Yoo; John H Sampson; Robert E Isaacs; Nicole A Larrier; Lawrence B Marks; Fang-Fang Yin; Q Jackie Wu; Zhiheng Wang; John P Kirkpatrick
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-10       Impact factor: 7.038

Review 5.  New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era.

Authors:  Camil Ciprian Mireștean; Anda Crișan; Adina Mitrea; Călin Buzea; Roxana Irina Iancu; Dragoș Petru Teodor Iancu
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

6.  External beam radiotherapy of recurrent glioma: radiation tolerance of the human brain.

Authors:  Peter Sminia; Ramona Mayer
Journal:  Cancers (Basel)       Date:  2012-04-05       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.